1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Waltho, J.P. Higgins, L.D. Craven, C.J. Tan, P. Dudgeon, T. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 274 16077 16084 10.1074/jbc.274.23.16077 10347159 Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. 1999 10.2210/pdb1b53/pdb pdb_00001b53 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 7678.577 MIP-1A D26A 2 man polymer no no SLAADTPTACCFSYTSRQIPQNFIAAYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA SLAADTPTACCFSYTSRQIPQNFIAAYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Pichia sample 9606 Homo sapiens 4922 Pichia pastoris database_2 pdbx_database_status struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Database references Other 1 0 1999-07-22 1 1 2008-03-24 1 2 2011-07-13 1 3 2012-02-22 1 4 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details Y BNL 1999-01-11 REL MEAN STRUCTURE. THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY ON 13C, 15N-LABELLED MIP-1A. ADDITIONAL INTERMONOMER CONSTRAINTS WERE ACQUIRED USING A MIXED 13C/15N-12C/14N SAMPLE. 30 1 ST ARD HETERONUCLEAR TECHNIQUES NO ADDED SALT 3.5 1 atm 318 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE SIMULATED ANNEALING STARTING FROM RANDOM ATOM POSITIONS 10% H2O/90% D2O BRUNGER refinement X-PLOR 3.1 structure solution X-PLOR 500 Bruker AMX500 SER 1 n 1 SER 1 A LEU 2 n 2 LEU 2 A ALA 3 n 3 ALA 3 A ALA 4 n 4 ALA 4 A ASP 5 n 5 ASP 5 A THR 6 n 6 THR 6 A PRO 7 n 7 PRO 7 A THR 8 n 8 THR 8 A ALA 9 n 9 ALA 9 A CYS 10 n 10 CYS 10 A CYS 11 n 11 CYS 11 A PHE 12 n 12 PHE 12 A SER 13 n 13 SER 13 A TYR 14 n 14 TYR 14 A THR 15 n 15 THR 15 A SER 16 n 16 SER 16 A ARG 17 n 17 ARG 17 A GLN 18 n 18 GLN 18 A ILE 19 n 19 ILE 19 A PRO 20 n 20 PRO 20 A GLN 21 n 21 GLN 21 A ASN 22 n 22 ASN 22 A PHE 23 n 23 PHE 23 A ILE 24 n 24 ILE 24 A ALA 25 n 25 ALA 25 A ALA 26 n 26 ALA 26 A TYR 27 n 27 TYR 27 A PHE 28 n 28 PHE 28 A GLU 29 n 29 GLU 29 A THR 30 n 30 THR 30 A SER 31 n 31 SER 31 A SER 32 n 32 SER 32 A GLN 33 n 33 GLN 33 A CYS 34 n 34 CYS 34 A SER 35 n 35 SER 35 A LYS 36 n 36 LYS 36 A PRO 37 n 37 PRO 37 A GLY 38 n 38 GLY 38 A VAL 39 n 39 VAL 39 A ILE 40 n 40 ILE 40 A PHE 41 n 41 PHE 41 A LEU 42 n 42 LEU 42 A THR 43 n 43 THR 43 A LYS 44 n 44 LYS 44 A ARG 45 n 45 ARG 45 A SER 46 n 46 SER 46 A ARG 47 n 47 ARG 47 A GLN 48 n 48 GLN 48 A VAL 49 n 49 VAL 49 A CYS 50 n 50 CYS 50 A ALA 51 n 51 ALA 51 A ASP 52 n 52 ASP 52 A PRO 53 n 53 PRO 53 A SER 54 n 54 SER 54 A GLU 55 n 55 GLU 55 A GLU 56 n 56 GLU 56 A TRP 57 n 57 TRP 57 A VAL 58 n 58 VAL 58 A GLN 59 n 59 GLN 59 A LYS 60 n 60 LYS 60 A TYR 61 n 61 TYR 61 A VAL 62 n 62 VAL 62 A SER 63 n 63 SER 63 A ASP 64 n 64 ASP 64 A LEU 65 n 65 LEU 65 A GLU 66 n 66 GLU 66 A LEU 67 n 67 LEU 67 A SER 68 n 68 SER 68 A ALA 69 n 69 ALA 69 A SER 1 n 1 SER 1 B LEU 2 n 2 LEU 2 B ALA 3 n 3 ALA 3 B ALA 4 n 4 ALA 4 B ASP 5 n 5 ASP 5 B THR 6 n 6 THR 6 B PRO 7 n 7 PRO 7 B THR 8 n 8 THR 8 B ALA 9 n 9 ALA 9 B CYS 10 n 10 CYS 10 B CYS 11 n 11 CYS 11 B PHE 12 n 12 PHE 12 B SER 13 n 13 SER 13 B TYR 14 n 14 TYR 14 B THR 15 n 15 THR 15 B SER 16 n 16 SER 16 B ARG 17 n 17 ARG 17 B GLN 18 n 18 GLN 18 B ILE 19 n 19 ILE 19 B PRO 20 n 20 PRO 20 B GLN 21 n 21 GLN 21 B ASN 22 n 22 ASN 22 B PHE 23 n 23 PHE 23 B ILE 24 n 24 ILE 24 B ALA 25 n 25 ALA 25 B ALA 26 n 26 ALA 26 B TYR 27 n 27 TYR 27 B PHE 28 n 28 PHE 28 B GLU 29 n 29 GLU 29 B THR 30 n 30 THR 30 B SER 31 n 31 SER 31 B SER 32 n 32 SER 32 B GLN 33 n 33 GLN 33 B CYS 34 n 34 CYS 34 B SER 35 n 35 SER 35 B LYS 36 n 36 LYS 36 B PRO 37 n 37 PRO 37 B GLY 38 n 38 GLY 38 B VAL 39 n 39 VAL 39 B ILE 40 n 40 ILE 40 B PHE 41 n 41 PHE 41 B LEU 42 n 42 LEU 42 B THR 43 n 43 THR 43 B LYS 44 n 44 LYS 44 B ARG 45 n 45 ARG 45 B SER 46 n 46 SER 46 B ARG 47 n 47 ARG 47 B GLN 48 n 48 GLN 48 B VAL 49 n 49 VAL 49 B CYS 50 n 50 CYS 50 B ALA 51 n 51 ALA 51 B ASP 52 n 52 ASP 52 B PRO 53 n 53 PRO 53 B SER 54 n 54 SER 54 B GLU 55 n 55 GLU 55 B GLU 56 n 56 GLU 56 B TRP 57 n 57 TRP 57 B VAL 58 n 58 VAL 58 B GLN 59 n 59 GLN 59 B LYS 60 n 60 LYS 60 B TYR 61 n 61 TYR 61 B VAL 62 n 62 VAL 62 B SER 63 n 63 SER 63 B ASP 64 n 64 ASP 64 B LEU 65 n 65 LEU 65 B GLU 66 n 66 GLU 66 B LEU 67 n 67 LEU 67 B SER 68 n 68 SER 68 B ALA 69 n 69 ALA 69 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A B HB3 HB2 SER ALA 13 4 1.12 1 A B HB2 O SER ALA 13 4 1.27 1 A B HD2 OG1 PHE THR 12 8 1.57 1 A B CB O SER ALA 13 4 2.17 1 A TYR 14 0.445 SIDE CHAIN 1 A ARG 45 0.283 SIDE CHAIN 1 A ARG 47 0.295 SIDE CHAIN 1 B TYR 14 0.445 SIDE CHAIN 1 B ARG 45 0.283 SIDE CHAIN 1 B ARG 47 0.295 SIDE CHAIN 1 -10.57 0.60 121.00 110.43 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 1 -67.48 1.10 117.90 50.42 A A A CD1 CG CD2 TYR TYR TYR 14 14 14 N 1 15.00 0.60 121.00 136.00 A A A CB CG CD1 TYR TYR TYR 14 14 14 N 1 -43.98 0.80 121.30 77.32 A A A CG CD1 CE1 TYR TYR TYR 14 14 14 N 1 -45.66 0.80 121.30 75.64 A A A CG CD2 CE2 TYR TYR TYR 14 14 14 N 1 -44.16 0.90 119.80 75.64 A A A CD1 CE1 CZ TYR TYR TYR 14 14 14 N 1 -68.80 1.60 119.80 51.00 A A A CE1 CZ CE2 TYR TYR TYR 14 14 14 N 1 -42.41 0.90 119.80 77.39 A A A CZ CE2 CD2 TYR TYR TYR 14 14 14 N 1 -10.56 0.60 121.00 110.44 B B B CB CG CD2 TYR TYR TYR 14 14 14 N 1 -67.49 1.10 117.90 50.41 B B B CD1 CG CD2 TYR TYR TYR 14 14 14 N 1 14.98 0.60 121.00 135.98 B B B CB CG CD1 TYR TYR TYR 14 14 14 N 1 -43.98 0.80 121.30 77.32 B B B CG CD1 CE1 TYR TYR TYR 14 14 14 N 1 -45.64 0.80 121.30 75.66 B B B CG CD2 CE2 TYR TYR TYR 14 14 14 N 1 -44.16 0.90 119.80 75.64 B B B CD1 CE1 CZ TYR TYR TYR 14 14 14 N 1 -68.78 1.60 119.80 51.02 B B B CE1 CZ CE2 TYR TYR TYR 14 14 14 N 1 -42.40 0.90 119.80 77.40 B B B CZ CE2 CD2 TYR TYR TYR 14 14 14 N 1 A LEU 2 -161.13 -155.36 1 A ALA 3 -62.46 -142.75 1 A THR 6 160.24 126.00 1 A THR 8 -53.22 90.84 1 A ALA 9 -48.22 108.43 1 A CYS 11 -101.23 77.60 1 A ALA 25 -149.50 -38.65 1 A ALA 26 -109.34 -145.80 1 A TYR 27 178.78 -43.50 1 A PHE 28 46.99 -173.53 1 A GLU 29 -164.17 39.01 1 A THR 30 42.37 -143.67 1 A SER 31 -177.77 -166.09 1 A GLN 33 78.31 -29.84 1 A LYS 36 -116.01 77.93 1 A PRO 37 -82.15 31.03 1 A THR 43 -41.61 159.53 1 A SER 46 45.87 25.53 1 A SER 54 -166.73 35.87 1 A LEU 67 171.42 64.08 1 B LEU 2 -161.18 -155.44 1 B ALA 3 -62.40 -142.74 1 B THR 6 160.30 125.99 1 B THR 8 -53.23 90.85 1 B ALA 9 -48.14 108.40 1 B CYS 11 -101.23 77.62 1 B ALA 25 -149.52 -38.64 1 B ALA 26 -109.34 -145.77 1 B TYR 27 178.76 -43.46 1 B PHE 28 47.22 -173.56 1 B GLU 29 -164.21 38.99 1 B THR 30 42.39 -143.68 1 B SER 31 -177.79 -166.09 1 B GLN 33 78.28 -29.84 1 B LYS 36 -115.94 77.89 1 B PRO 37 -82.11 31.03 1 B THR 43 -41.59 159.46 1 B SER 46 45.88 25.51 1 B SER 54 -166.79 35.91 1 B LEU 67 171.38 64.08 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 NMR STRUCTURE OF HUMAN MIP-1A D26A, MINIMIZED AVERAGE STRUCTURE 1 N N 1 N N A GLN 21 A GLN 21 HELX_P A PHE 23 A PHE 23 5 1 3 A VAL 58 A VAL 58 HELX_P A SER 63 A SER 63 1 2 6 B GLN 21 B GLN 21 HELX_P B PHE 23 B PHE 23 5 3 3 B VAL 58 B VAL 58 HELX_P B SER 63 B SER 63 1 4 6 disulf 2.021 A CYS 10 A SG CYS 10 1_555 A CYS 34 A SG CYS 34 1_555 disulf 2.717 A CYS 10 A SG CYS 10 1_555 B CYS 10 B SG CYS 10 1_555 disulf 2.021 A CYS 11 A SG CYS 11 1_555 A CYS 50 A SG CYS 50 1_555 disulf 2.953 A CYS 34 A SG CYS 34 1_555 B CYS 10 B SG CYS 10 1_555 disulf 2.973 A CYS 34 A SG CYS 34 1_555 B CYS 34 B SG CYS 34 1_555 disulf 2.020 B CYS 10 B SG CYS 10 1_555 B CYS 34 B SG CYS 34 1_555 disulf 2.022 B CYS 11 B SG CYS 11 1_555 B CYS 50 B SG CYS 50 1_555 CHEMOKINE CHEMOKINE, CYTOKINE, CHEMOTAXIS CCL3_HUMAN UNP 1 1 P10147 MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEW VQKYVSDLELSA 24 92 1B53 1 69 P10147 A 1 1 69 24 92 1B53 1 69 P10147 B 1 1 69 1 ASP engineered mutation ALA 26 1B53 A P10147 UNP 49 26 2 ASP engineered mutation ALA 26 1B53 B P10147 UNP 49 26 1 P 1